Company Logo
US NY Suffolk County Shirley Pharmaceutical Information

Rucaparib Camsylate

Pharmaceutical Information

Updated on Apr 19, 2019

View more like this | Visit SHIRLEY, NY | Contact BOC Smith
Rucaparib camsylate is an inhibitor of poly (ADP-ribose) polymerase (PARP) enzymes, which work in DNA repair process. It was approved for the treatment of ovarian cancer, and Rubraca is proved to be a monotherapy for the patients deleterious BRCA mutation associated advanced ovarian cancer who were treated with two or more chemotherapies.
Image for Rucaparib Camsylate with ID of: 3389663
View all posts by BOC SmithIs this your business? Claim this post.Contact BOC Smith
goodideazs, LLC is not affiliated with the authors of this post nor is it responsible for its content, the accuracy and authenticity of which should be independently verified.